Akero Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 7 20:00

Akero Therapeutics Insider Sold Shares Worth $280,330, According to a Recent SEC Filing

MT NewswiresJan 7 03:13

BofA Securities Maintains Akero Therapeutics(AKRO.US) With Hold Rating, Announces Target Price $35

Futu NewsJan 6 19:31 · Ratings

Evercore Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $38

Futu NewsDec 16, 2024 21:33 · Ratings

Possible Bearish Signals With Akero Therapeutics Insiders Disposing Stock

Simply Wall StDec 15, 2024 20:18

Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference

Akero TherapeuticsNov 26, 2024 13:00